Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review. [PDF]
Aguiar P, Bernat JA, Hughes D.
europepmc +1 more source
Newborn screening for Fabry disease in Japan: an additional 3-year report. [PDF]
Sawada T +6 more
europepmc +1 more source
Proxy patients' perceptions of genetic counselor empathy responses. [PDF]
Bouchard J +4 more
europepmc +1 more source
Neurological management and outcome measures in Fabry disease: consensus statements from the Italian Fabry disease neurological working group. [PDF]
Mancuso M +15 more
europepmc +1 more source
Persistent Hematuria and Proteinuria in a Patient with SLE Nephritis. [PDF]
Singh T, Panzer SE, Garg S.
europepmc +1 more source
Renal involvement in Fabry disease from Tunisian families: Six case reports. [PDF]
Tlili S +5 more
europepmc +1 more source
Liver Gene Therapy in Fabry Disease Mice With Low Doses of rAAV2/8 Expressing a Codon-Optimized hGLA cDNA Results in Long-Term Disease Correction. [PDF]
Saxena H +11 more
europepmc +1 more source
Large-Diameter Diaphragm Fabry-Pérot Interferometer for High-Sensitivity Temperature Sensing Using a Hermetically Sealed Tunable Medium: Up to 190 nm/K. [PDF]
Weir A +4 more
europepmc +1 more source
Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series. [PDF]
He Z, Wu Y, Yang H, Li Y, Xu L.
europepmc +1 more source

